Careful analysis of GBM from different stages revealed that MACF1 is highly expressed in grade IV GBM but not in surrounding normal tissues or lower grade GBM, revealing its potential as a prognostic marker for this type of cancer (Afghani et al., 2017). The gene discussed is MACF1; the disease is glioblastoma.